✦ LIBER ✦

Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852

Book ID: 122791563
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 309 KB
Volume: 11
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(94)92212-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interstitial lung disease in patients wi

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

✍ Masahiro Tsuboi; Thierry Le Chevalier 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 111 KB

Epidermal growth factor receptor polymor

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib

✍ Liu, G; Gurubhagavatula, S; Zhou, W; Wang, Z; Yeap, B Y; Asomaning, K; Su, L; He 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Predictive and Prognostic Impact of Epid

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib

✍ Han, S.-W. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 132 KB

Epidermal Growth Factor Receptor Mutatio

Epidermal Growth Factor Receptor Mutations and Response to Chemotherapy in Patients with Non-Small-Cell Lung Cancer

✍ Lee, K.-H. 📂 Article 📅 2006 🏛 Oxford University Press 🌐 English ⚖ 221 KB

The impact of epidermal growth factor re

The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer

✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor

Significance of pretreatment comorbiditi

Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor

✍ Kaoru Irisa; Katsuhiro Masago; Yosuke Togashi; Shiro Fujita; Yukimasa Hatachi; A 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 294 KB